NasdaqGM - Nasdaq Real Time Price USD

Fulgent Genetics, Inc. (FLGT)

19.04

+0.14

+(0.74%)

At close: 4:00:00 PM EDT

19.04

0.00

(0.00%)

After hours: 4:05:08 PM EDT

Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

Fulgent Genetics Inc (FLGT) reports robust fourth-quarter growth and outlines strategic plans for 2025 despite anticipated challenges.

GuruFocus.com 3 days ago

FLGT
+0.74%
Fulgent Genetics (NASDAQ:FLGT) shareholders have endured a 69% loss from investing in the stock three years ago

The truth is that if you invest for long enough, you're going to end up with some losing stocks. Long term Fulgent...

Simply Wall St. 13 days ago

FLGT
+0.74%
Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

EL MONTE, Calif., April 10, 2025--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its first quarter 2025 financial results before the market opens on Friday, May 2, 2025. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.

Business Wire 14 days ago

FLGT
+0.74%
Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?

Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks last month

FLGT
+0.74%
Fulgent Genetics Full Year 2024 Earnings: EPS Beats Expectations

Fulgent Genetics ( NASDAQ:FLGT ) Full Year 2024 Results Key Financial Results Revenue: US$283.5m (down 2.0% from FY...

Simply Wall St. last month

FLGT
+0.74%
Q4 2024 Fulgent Genetics Inc Earnings Call

Q4 2024 Fulgent Genetics Inc Earnings Call

Thomson Reuters StreetEvents last month

FLGT
+0.74%
Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates

Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 133.33% and 1.90%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

FLGT
+0.74%
Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

EL MONTE, Calif., February 28, 2025--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2024.

Business Wire last month

FLGT
+0.74%
TruBridge (TBRG) Soars 6.4%: Is Further Upside Left in the Stock?

TruBridge (TBRG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks 2 months ago

FLGT
+0.74%
Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

EL MONTE, Calif., February 06, 2025--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Friday, February 28, 2025. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the resul

Business Wire 2 months ago

FLGT
+0.74%
Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 2 months ago

SDGR

FLGT
+0.74%
With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing

Key Insights Given the large stake in the stock by institutions, Fulgent Genetics' stock price might be vulnerable to...

Simply Wall St. 4 months ago

FLGT
+0.74%
Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know

The mean of analysts' price targets for Fulgent Genetics (FLGT) points to a 31.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks 4 months ago

FLGT
+0.74%
All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy

Fulgent Genetics (FLGT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks 4 months ago

FLGT
+0.74%
Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Fulgent Genetics, Inc. (NASDAQ:FLGT) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in the genomics […]

Insider Monkey 5 months ago

FLGT
+0.74%
Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Simply Wall St. 5 months ago

FLGT
+0.74%
Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations

Fulgent Genetics ( NASDAQ:FLGT ) Third Quarter 2024 Results Key Financial Results Revenue: US$71.7m (down 15% from 3Q...

Simply Wall St. 5 months ago

FLGT
+0.74%
Fulgent Genetics Reports Strong Q3 2024 Results

Fulgent Genetics ( (FLGT) ) has provided an announcement. Fulgent Genetics reported third-quarter 2024 financial results, showcasing a total revenue of $71.7 million with a 9% year-over-year growth in core revenue. While the company faced a GAAP loss of $14.6 million, it achieved a non-GAAP income of $9.4 million. Fulgent remains optimistic about its full-year core revenue guidance of $280 million and improved earnings per share. The company continues to advance its laboratory services and thera

TipRanks 5 months ago

FLGT
+0.74%
Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline

Despite a drop in revenue, Fulgent Genetics Inc (FLGT) showcases strong cash reserves and strategic advancements in precision diagnostics and oncology.

GuruFocus.com 5 months ago

FLGT
+0.74%
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates

Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 263.16% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 months ago

FLGT
+0.74%

Performance Overview

Return	FLGT	S&P 500 (^GSPC)
YTD	+3.09%	-6.75%
1-Year	-8.20%	+8.15%
3-Year	-66.27%	+28.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

Fulgent Genetics (NASDAQ:FLGT) shareholders have endured a 69% loss from investing in the stock three years ago

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?

Fulgent Genetics Full Year 2024 Earnings: EPS Beats Expectations

Q4 2024 Fulgent Genetics Inc Earnings Call

Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

TruBridge (TBRG) Soars 6.4%: Is Further Upside Left in the Stock?

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing

Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know

All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy

Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now

Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth

Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations

Fulgent Genetics Reports Strong Q3 2024 Results

Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline

Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates

Performance Overview